TELO2
protein-codingtelomere maintenance 2, the group of Armadillo like helical domain containing|TTT complex
Gene summary
This gene encodes a protein that functions as an S-phase checkpoint protein in the cell cycle. The protein may also play a role in DNA repair.[provided by RefSeq, Mar 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014848
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014848
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014848
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014848
Submitter: ClinGen
*TELO2* was first reported in relation to autosomal recesssive syndromic intellectual disability and neurodevelopmental disorder in 2016 (You et al., PMID:27132593). *TELO2*-related intellectual disability-neurodevelopmental disorder (You-Hoover-Fong syndrome) is characterized by delayed global development, microcephaly, abnormal balance, and a movement disorder. At least 11 variants (including missense, nonsense, frameshift, exonic deletion) have been reported (PMID: 28944240, 33307281, 32940098). Evidence supporting this gene-disease relationship includes case-level and experimental data. In summary, there is definitive evidence supporting the relationship between *TELO2* and *TELO2*-related intellectual disability-neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on June 1, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0014848
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TELO2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016111.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 170 | 10 | 185 | ||
| missense | 1 | 9 | 246 | 44 | 10 | 310 |
| nonsense | 1 | 4 | 2 | 7 | ||
| start loss | 1 | 1 | ||||
| frameshift | 10 | 4 | 1 | 15 | ||
| splice donor/acceptor (+/-2bp) | 9 | 6 | 15 | |||
| Total | 12 | 27 | 260 | 214 | 20 | 533 |
Highest pathogenic variant AF is 0.00018075545
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057195.2 | 20 | MANE Select | |
| Ensembl | ENSP00000262319.6 | 20 | MANE Select | |
| RefSeq | NP_001338775.1 | 20 | Standard | |
| Ensembl | ENSP00000456383.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fanconi anemia pathway - Homo sapiens (human)
- mTOR signaling pathway - Homo sapiens (human)
- Steatosis AOP
Biological Process
- telomere maintenance
- regulation of TOR signaling
- protein stabilization
- positive regulation of protein serine/threonine kinase activity
- positive regulation of TORC1 signaling
Molecular Function
- protein binding
- protein kinase binding
- protein-containing complex scaffold activity
- telomeric DNA binding
- protein-containing complex binding
Cellular Component
- nuclear chromosome, telomeric region
- nucleus
- cytoplasm
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262319
- Coding exons
- 20
- Length
- 17114
- Individuals with no LoFs
- 125677
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 68
- Defined
- 125745
- p
- 0.000270
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.367 | 568 | 544 | 1.04 | 0.0000379 | 5237 |
| Missense (PolyPhen) | 105 | 117.32 | 0.89499 | 1314 | ||
| Synonymous | -1.95 | 294 | 254 | 1.16 | 0.0000184 | 1838 |
| Loss of Function | 1.93 | 27 | 40.2 | 0.672 | 0.00000209 | 424 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00028 | 0.00025 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00098 | 0.00092 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00029 | 0.00027 | rare |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.00018 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. May be involved in telomere length regulation. {ECO:0000269|PubMed:12670948, ECO:0000269|PubMed:20810650}.;
- Disease
- DISEASE: You-Hoover-Fong syndrome (YHFS) [MIM:616954]: A syndrome characterized by severe global developmental delay, intellectual disability, dysmorphic facial features, microcephaly, abnormal movements, congenital heart disease comprising developmental abnormalities of the great vessels, and abnormal auditory and visual function. The transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:27132593}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- LoFtool
- 0.217
- RVIS EVS
- 0.42
- RVIS percentile EVS
- 76.68
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.643
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |